104 related articles for article (PubMed ID: 3718409)
1. Distribution of alpha-polymers and residual alpha-chains in in vitro and in vivo formed fibrin clots.
Barthels M; Förstermann U; Sosada M; Poliwoda H
Behring Inst Mitt; 1986 Feb; (79):24-30. PubMed ID: 3718409
[TBL] [Abstract][Full Text] [Related]
2. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
Glover CJ; McIntire LV; Brown CH; Natelson EA
J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
[TBL] [Abstract][Full Text] [Related]
3. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
[TBL] [Abstract][Full Text] [Related]
5. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
Kobbervig C; Williams E
Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and fibrin clot structure.
Wolberg AS
Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
[TBL] [Abstract][Full Text] [Related]
7. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers.
Langer BG; Weisel JW; Dinauer PA; Nagaswami C; Bell WR
J Biol Chem; 1988 Oct; 263(29):15056-63. PubMed ID: 3170575
[TBL] [Abstract][Full Text] [Related]
8. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
[TBL] [Abstract][Full Text] [Related]
9. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
[TBL] [Abstract][Full Text] [Related]
10. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
[TBL] [Abstract][Full Text] [Related]
11. Factor XIII, fibrin and collagen.
Duckert F; Nyman D
Suppl Thromb Haemost; 1978; 63():391-6. PubMed ID: 262335
[TBL] [Abstract][Full Text] [Related]
12. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
Francis CW; Marder VJ
J Clin Invest; 1987 Nov; 80(5):1459-65. PubMed ID: 3680507
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants.
Hickerson WL; Nur I; Meidler R
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):19-23. PubMed ID: 21150581
[TBL] [Abstract][Full Text] [Related]
14. gamma-dimerization, alpha-polymerization, and plasmin degradation of human fibrin. Effect of various inhibitors of factor XIII on the patterns in SDS-electrophoresis and crossed immunoelectrophoresis.
Feddersen JC; Gormsen J
Thromb Haemost; 1976 Aug; 36(1):27-36. PubMed ID: 137555
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
[TBL] [Abstract][Full Text] [Related]
16. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and Factor XIII deficient plasmas.
Nielsen VG; Kirklin JK; George JF; Messinger JD
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):101-5. PubMed ID: 19844175
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
19. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of thrombospondin into fibrin clots.
Bale MD; Westrick LG; Mosher DF
J Biol Chem; 1985 Jun; 260(12):7502-8. PubMed ID: 3997886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
